Niacin Extended Release (ER)/Simvastatin (Simcor®): A Guide to its Use in Lipid Regulation

Oral fixed-dose niacin extended release/simvastatin is associatedwith clinically relevant improvements in plasma lipid profiles, including lowering of nonhigh- density lipoprotein cholesterol levels, relative to simvastatinmonotherapy in patients with mixed dyslipidemias who had not responded fully...

Descripción completa

Detalles Bibliográficos
Autor principal: Lyseng-Williamson, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Drug and Profile Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586144/
https://www.ncbi.nlm.nih.gov/pubmed/21171671
http://dx.doi.org/10.2165/11202560-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586144/
https://www.ncbi.nlm.nih.gov/pubmed/21171671
http://dx.doi.org/10.2165/11202560-000000000-00000

Ejemplares similares